Clinical Trial in Chinese Healthy Volunteers of GB222

NCT04175158 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: GB222
BIOLOGICAL: Bevacizumab

Sponsor

Genor Biopharma Co., Ltd.